BusinessTrending
CVS Health announced plans to separate its retail pharmacy business from its insurance and pharmacy services operations, a process expected to be completed in the first half of 2028.
CVS Health announced on Wednesday, November 4, 2026, that it intends to separate into two independent, publicly traded companies. The decision follows a comprehensive strategic review by the CVS Health Board of Directors. The separation is expected to be completed in the first half of 2028 and is intended to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes.
The planned separation will create two distinct entities:
Upon completion of the split, CVS Health shareholders will own shares in both companies. Both companies are expected to maintain solid investment-grade credit ratings and strong free cash flow.
The move represents a reversal of a long-term strategy to combine retail pharmacy, health insurance, and pharmacy-benefit management. CVS Health previously expanded through major acquisitions, including a roughly $78 billion purchase of the health insurer Aetna in 2018. This restructuring dismantles a conglomerate that has been built through decades of acquisitions.
Following the announcement, CVS shares experienced a decline. Reports indicated shares were down more than 10% in early trading, with one report stating shares fell 12.6% to $79.94. Analysts noted the timing of the move may be influenced by the company's recent financial performance. CVS reported third-quarter 2026 results with a per-share profit of $2.09, which exceeded the analysts' average estimate of $1.65. The company also raised its annual adjusted profit forecast to at least $8.20.
The restructuring comes as the healthcare industry faces various economic and regulatory pressures. Health insurers have been dealing with elevated medical costs as consumers increase their use of healthcare services. Simultaneously, retail pharmacies face competition from Amazon and a shift toward prescription delivery, which has reduced physical store visits.
Additionally, the split occurs amid growing scrutiny from lawmakers and regulators regarding vertically integrated healthcare companies. Some analysts suggest that a separation could help address regulatory concerns regarding whether controlling multiple parts of the healthcare supply chain creates conflicts of interest or limits competition. Morningstar analyst Julie Utterback noted that CVS has "the most exposure to vertical integration in the industry."
The separation aims to allow each company to pursue a more focused strategic agenda. According to CVS Health, the healthcare solutions company will focus on delivering comprehensive benefits, while CVS Pharmacy will focus on serving as a consumer health touchpoint. Both companies intend to continue advancing technology, including the launch of Health100, which will deliver AI-native products and services designed to address healthcare challenges.
Sources
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
No comments yet. Start the discussion.
BusinessTrending
Air India has introduced a new seasonal service connecting Mumbai and Toronto with three weekly direct flights, increasing capacity between India and Canada.
China's National Development and Reform Commission has prohibited SoftBank's $5.4 billion takeover of ABB's robotics business, a move impacting SoftBank's physical AI ambitions.
